CCR4 Is Critically Involved in Skin Allergic Inflammation of BALB/c Mice-Reference-Cited by-同舟云学术

CCR4 Is Critically Involved in Skin Allergic Inflammation of BALB/c Mice

Published:2018-08 Issue:8 Volume:138 Page:1764-1773
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Matsuo Kazuhiko,Nagakubo Daisuke,Komori Yuhei,Fujisato Shun,Takeda Natsumi,Kitamatsu Mizuki,Nishiwaki Keiji,Quan Ying-Shu,Kamiyama Fumio,Oiso Naoki,Kawada Akira,Yoshie Osamu,Nakayama Takashi

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference51 articles.

1. Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen;Alferink;J Exp Med,2003

2. Mast cells are required for full expression of allergen/SEB-induced skin inflammation;Ando;J Invest Dermatol,2013

3. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors;Bachelerie;Pharmacol Rev,2013

4. Regulation of T cell immunity in atopic dermatitis by microbes: the yin and yang of cutaneous inflammation;Biedermann;Front Immunol,2015

5. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation;Boguniewicz;Immunol Rev,2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical application of a CCL22-binding aptamer suppresses contact allergy;Molecular Therapy - Nucleic Acids;2024-09

2. Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations;Journal of Allergy and Clinical Immunology;2024-07

3. Monotropein mitigates atopic dermatitis-like skin inflammation through JAK/STAT signaling pathway inhibition;Biomedicine & Pharmacotherapy;2024-07

4. Immune cell trafficking: a novel perspective on the gut-skin axis;Inflammation and Regeneration;2024-04-24

5. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments;Antibodies;2024-04-22